Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients ; volume:24 ; number:1 ; day:23 ; month:2 ; year:2024 ; pages:1-8 ; date:12.2024
BMC gastroenterology ; 24, Heft 1 (23.2.2024), 1-8, 12.2024
- Creator
-
Wang, Mengyun
Tang, Shuzhen
Li, Guoqiu
Huang, Zhibin
Mo, Sijie
Yang, Keen
Chen, Jing
Du, Baishan
Xu, Jinfeng
Ding, Zhimin
Dong, Fajin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-024-03160-8
- URN
-
urn:nbn:de:101:1-2404301306139.805815632147
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Mengyun
- Tang, Shuzhen
- Li, Guoqiu
- Huang, Zhibin
- Mo, Sijie
- Yang, Keen
- Chen, Jing
- Du, Baishan
- Xu, Jinfeng
- Ding, Zhimin
- Dong, Fajin
- SpringerLink (Online service)
Other Objects (12)
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
Predicting of hepatic steatosis in living liver donor via CT liver attenuation index (LAI) and fibroscan controlled attenuation parameter (CAP) correlation with biopsy result
Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
CT attenuation values predict liver injury in COVID-19 patients
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis
Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter